1. Home
  2. THRD

THRD

Third Harmonic Bio Inc.

Logo Third Harmonic Bio Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-17-2024 11:41am EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

Founded: 2019 Country:
United States
United States
Employees: N/A City: SAN FRANCISCO
Market Cap: 411.2M IPO Year: 2022
Target Price: $7.00 AVG Volume (30 days): 130.2K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.78 EPS Growth: N/A
52 Week Low/High: $4.06 - $12.42 Next Earning Date: 05-09-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: